This article, in support of “OncoPRO,” provides the final results of the PRO-TECT trial. It shows significant and clinically meaningful benefits of ePRO symptom monitoring on quality of life, physical function, and symptom control, as well as significant decrease in emergency room visits without impact on survival.
Citation Information:
Basch E, Schrag D, Jansen J, Henson S, Ginos B, Stover AM, Carr P, Spears PA, Jonsson M, Deal AM, Bennett AV, Thanarajasingam G, Rogak L, Reeve BB, Snyder C, Bruner D, Cella D, Kottschade LA, Perlmutter J, Geoghegan C, Given B, Mazza GL, Miller R, Strasser JF, Zylla DM, Weiss A, Blinder VS, Wolf AP, Dueck AC. Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial. Nat Med. 2025 Apr;31(4):1225-1232. doi: 10.1038/s41591-025-03507-y. Epub 2025 Feb 7. PMID: 39920394. https://www.nature.com/articles/s41591-025-03507-y